Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trial
- 1 April 1997
- journal article
- research article
- Published by American Psychiatric Association Publishing in American Journal of Psychiatry
- Vol. 154 (4) , 457-465
- https://doi.org/10.1176/ajp.154.4.457
Abstract
OBJECTIVE: This international, multicenter double-blind trial was designed to compare the therapeutic profile of an atypical antipsychotic, olanzapine, with that of a conventional dopamine D2 antag...Keywords
This publication has 28 references indexed in Scilit:
- Dopamine D2 receptor occupancy in vivo by the novel atypical antipsychotic olanzapine — a123 IBZM single photon emission tomography (SPET) studyPsychopharmacology, 1996
- Olanzapine versus placebo: results of a double-blind, fixed-dose olanzapine trialPsychopharmacology, 1996
- Electrophysiological Effects of Olanzapine, a Novel Atypical Antipsychotic, on A9 and A10 Dopamine NeuronsNeuropsychopharmacology, 1996
- Radioreceptor Binding Profile of the Atypical Antipsychotic OlanzapineNeuropsychopharmacology, 1996
- Antipsychotic agents antagonize non-competitiveN-methyl-d-aspartate antagonist-induced behaviorsPsychopharmacology, 1995
- Evaluation of nefazodone as a serotonin uptake inhibitor and a serotonin antagonist in vivoLife Sciences, 1994
- National Institute of Mental Health Longitudinal Study of Chronic SchizophreniaArchives of General Psychiatry, 1991
- Clozapine: neuroleptic-induced EPS and tardive dyskinesiaPsychopharmacology, 1989
- Clozapine for the Treatment-Resistant SchizophrenicArchives of General Psychiatry, 1988
- Cytotoxic effects of neuroleptic drugsPsychopharmacology, 1987